My Cancer Journey

What My Cancer Journey does

My Cancer Journey, doing business as Ardynn, is a private cancer patient advocacy service that assigns each member a dedicated advocate to support them through diagnosis, treatment, and post-treatment care. The advocate helps the patient understand complex medical information, articulates goals and preferences through a personalized report that can be shared with the oncology team, attends medical appointments virtually, and connects the member to relevant services and resources. The service is operated under parent company PotentiaMetrics, Inc., with Austin, Texas as the headquarters location and a website at mycancerjourney.com (also referenced as ardynn.com).

The core technology is Capire360, a wholly-owned subsidiary tool within PotentiaMetrics that provides treatment decision support using real-world clinical outcomes data sourced from over 500 medical centers and encompassing millions of cancer patients. The data is stratified by age, sex, race, health status, and diagnosis, allowing members to see outcomes for patients with similar profiles. The company explicitly positions Capire360 as not AI-based, relying instead on clinical registry analytics and the proprietary PotentiaMetrics data platform.

Ardynn monetizes through three subscription-based revenue streams: individual memberships paid out-of-pocket by patients and families, employer-sponsored benefit programs accessed via benefits consultants, and health plan partnerships that integrate advocacy as a member benefit. A fourth channel engages healthcare providers as a liaison service. Go-to-market is sales-led across all four segments, with separate Member Services and Partner Services contact lines. Pricing is quote-based and not publicly disclosed. Ownership is held by PotentiaMetrics, Inc., with no disclosed venture capital, private equity, or institutional funding rounds; no patents, awards, regulatory actions, leadership changes, or M&A activity are on record in the input data.

Name

My Cancer Journey

Legal name

PotentiaMetrics, Inc.

Website

https://mycancerjourney.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Ardynn (My Cancer Journey) is a private cancer patient advocacy service under PotentiaMetrics that assigns dedicated advocates and provides Capire360, a real-world clinical outcomes-based treatment decision tool, to patients, employers, health plans, and healthcare providers.

Ownership category

akta.pro rank

Product category

Cancer Patient Advocacy Services

NAICS

Other Individual and Family Services (624190)

SIC

Services-Health Services (8000), Services-Social Services (8300)

akta.pro primary industry

Patient Advocacy, Navigation & Access to Care (BPAGACAH)

akta.pro secondary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Cancer patient advocacy
• Treatment decision support
• Healthcare navigation services
• Employee cancer benefits
• Clinical outcomes data

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Individual Membership: Direct-to-consumer advocacy services for individuals and families paying out-of-pocket for cancer advocacy support. Services include dedicated advocate assignment, personalized reports, and Capire360 access.
2. Employer Benefit Programs: Cancer advocacy offered as an employee benefit through employers and benefits consultants. Employers provide the service as a benefit to employees and their families facing cancer diagnoses.
3. Health Plan Partnerships: Cancer advocacy services integrated as a member benefit for health plan members, optimizing healthcare utilization and improving member satisfaction.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Ardynn provides personalized cancer patient advocacy services in which dedicated advocates help individuals with cancer and their families understand diagnoses, evaluate treatment options, articulate goals to care teams, and access real-world outcomes data through the Capire360 decision support tool. Services are delivered to individual members, employer-sponsored populations, and health plan members.

Product overview

Ardynn is a private patient advocacy service structured as a unified platform with integrated tools. The core offering is personalized cancer advocacy, where dedicated advocates support patients throughout their cancer journey. The flagship product is Capire360, a treatment decision support tool that uses real-world outcomes data (not AI) to help patients understand how treatments impact others with similar circumstances. Additional services include personalized reports that capture patient goals and preferences for sharing with care teams, and virtual advocate appointment support. The company operates under parent organization PotentiaMetrics, Inc., which provides the underlying clinical registry data compiled from over 500 medical centers.

Differentiator

Problem solved

Functional benefit

Brands

• Capire360: A patient treatment decision support tool based on real-world results that allows members to see outcomes data for people with similar demographics and diagnosis.

Products and services

• Ardynn Cancer Patient Advocacy Service A private patient advocacy service for individuals diagnosed with cancer and their families, providing dedicated advocates who help patients understand their diagnosis, evaluate treatment options, articulate personal goals to care teams, and connect to services and resources throughout the cancer journey.
• Capire360 Treatment Decision Support A patient treatment decision support tool based on real-world clinical outcomes (not AI) that allows members to see the results of treatment choices made by people of the same age, sex, race, health status, and diagnosis, supporting informed, personalized care decisions.

Quantifiable outcome

• Oncologists spend average of only 25 minutes with patients during initial consultation
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• PotentiaMetrics, Inc.coreOthersPotentiaMetrics is the parent company of Ardynn and Capire360. It provides the underlying data platform powering Ardynn's cancer advocacy services, with clinical registry data from over 500 medical centers covering millions of cancer patients. The company is making healthcare personal with solutions that honor individual differences.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Jasper Health: A digital cancer care platform offering coaching, navigation, and symptom management for oncology patients and survivors. Comparable cancer-specific care navigation focus with a more digital-first delivery model than Ardynn's human-led approach.
• Color Health: A population health company combining genetic testing, cancer screening, and care navigation. Overlaps with Ardynn on cancer care navigation, particularly for employer and health plan customers, and uses clinical data at scale.

Broad incumbents

• Accolade: A large-scale personalized advocacy and healthcare navigation platform sold primarily to employers and health plans. Broader scope than Ardynn but operates a comparable dedicated-advocate model for complex conditions, including oncology.
• Included Health: A comprehensive virtual care and navigation provider combining primary care, mental health, and care advocacy for employer and payer clients. Broad incumbent with overlapping cancer navigation and high-touch advocacy capabilities.
• Quantum Health: A healthcare navigation and care coordination company serving primarily large self-funded employers. Operates a comparable high-touch advocacy model with demonstrated value in complex-condition navigation, including oncology.

Direct peers

• Triage Cancer: A national nonprofit providing cancer-focused education, navigation, and advocacy on insurance, finances, and employment issues. Direct peer in cancer-specific patient navigation and education.
• Patient Advocate Foundation: A national nonprofit providing case management and advocacy services to patients with chronic, life-threatening, and debilitating illnesses, including cancer. Direct competitor in the cancer patient advocacy space, particularly for payer-referred and underinsured populations.
• Carrum Health: A value-based care platform offering bundled oncology and other specialty care navigation to employers and health plans. Comparable employer/payer go-to-market and cancer navigation focus, with an emphasis on cost and outcomes rather than pure advocacy.
• Cancer Support Community: A global nonprofit network offering support, education, and navigation to people impacted by cancer. Operates a comparable patient advocacy and navigation model focused on psychosocial support alongside clinical decision support.
• Livestrong (Livestrong Foundation): Historically a major cancer advocacy organization providing navigation, fertility preservation, and direct support services to cancer patients. Highly comparable mission, audience, and service model to Ardynn's individual advocacy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/MyCaJourney

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about My Cancer Journey